Dipender is a clinician scientist, who trained in Medical Sciences at the University of Oxford and was awarded Distinction for his BM BCh. He went on to become a specialist registrar in clinical pharmacology and therapeutics at Imperial College Healthcare NHS Trust, and in 2013 became an Honorary Clinical Lecturer at Imperial College London. Most recently, Dipender has followed his research interests in Mendelian randomisation to identify causal risk factors and therapeutic targets for cardiovascular diseases, successfully defending his PhD thesis in Dec 2019. He has over 50 peer-reviewed manuscripts including 16 first author papers from his PhD. This includes work identifying genetic variants to proxy the effect of antihypertensive, anticoagulant and anti-inflammatory drugs.
Gill D, 2021, The relationship between blood pressure and incident cardiovascular disease: linear and non-linear Mendelian randomization analyses, Hypertension, ISSN:0194-911X
et al., 2021, Mendelian randomization for studying the effects of perturbing drug targets, Wellcome Open Research, Vol:6, Pages:16-16
et al., 2021, Inhibition of interleukin 6 signalling and renal function: A Mendelian randomization study, British Journal of Clinical Pharmacology, ISSN:0306-5251
et al., 2021, Genetically predicted circulating concentrations of micro-nutrients and risk of breast cancer: A Mendelian randomization study, International Journal of Cancer, Vol:148, ISSN:0020-7136, Pages:646-653
et al., 2021, Urate, blood pressure and cardiovascular disease: evidence from Mendelian randomization and meta-analysis of clinical trials, Hypertension, Vol:77, ISSN:0194-911X, Pages:383-392